XTL and Pharming Group in hepatitis C deal

XTL Biopharmaceuticals (LSE:XTL) and Pharming (EASD:PHAR) will jointly evaluate and potentially co-develop PHAR's recombinant human Lactoferrin to treat hepatitis C virus (HCV) infection. ...